ARTICLE

FindCenter AddIcon

MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients

By Maureen Meehan — 2017

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

Read on hightimes.com

FindCenter Post-Image

The Trip Treatment

Research into psychedelics, shut down for decades, is now yielding exciting results.

Article
Michael Pollan
2015
FindCenter AddIcon
FindCenter Post-Image

My Adventures with the Trip Doctors

My first psilocybin journey began around an altar in the middle of a second-story loft in a suburb of a small city on the Eastern Seaboard.

Article
Michael Pollan
2018
FindCenter AddIcon
FindCenter Post-Image

For the First Time, Scientists Have Imaged the Brain on LSD

The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.

Article
Victoria Turk
2016
FindCenter AddIcon
FindCenter Post-Image

Interview with Albert Hofmann, the Man Who First Synthesized LSD

The late chemist Albert Hofmann discussed his psychedelic research on LSD in the July, 1976 issue of High Times.

Article
High Times
2020
FindCenter AddIcon

EXPLORE TOPIC

MDMA